Clin2
NCT06637618Likely a fitNot yet recruiting

Heart failure medication order study

Heart Failure, Reduced Ejection Fraction

Part of Heart & circulation clinical trials.

This study looks at whether the order in which heart failure medications are started makes a difference. It compares different sequences to find the best way to begin treatment for newly diagnosed heart failure.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
16,000 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You must be at least 18 years old
  • You need a recent diagnosis of a specific type of heart failure called HFrEF, where the heart's main pumping chamber is weak
  • You must be starting or adjusting heart failure medications at an outpatient clinic

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07845201Not yet recruiting
Heart failure treatment outcomes study

This study looks at how well patients with heart failure and a weakened heart muscle (ejection fraction of 40% or lower) do when taking the recommended heart failure medications. The goal is to see if these treatments improve their heart function and quality of life.

NCT06526988Recruiting
Heart failure medication optimization study for clinicians and patients

This study tests tools to help doctors and patients work together to start or adjust heart failure medicines. You may qualify if your heart's pumping strength is low and you are missing certain recommended medications.

Walnut Creek, California
NCT07489352Enrolling by invitation
Heart failure medication adjustment study

This study tests a personalized approach to safely increase the dose of your heart failure medication (beta-blocker). It aims to improve your symptoms and overall heart function by tailoring the dose to your specific needs.

New York, New York
NCT06595290Recruiting
Faster medication increase for heart failure with weak pumping

This trial tests a new, faster way to increase heart failure medications during a hospital stay, aiming to get patients on the right doses sooner. It is for people with weak heart pumping (ejection fraction 40% or less) who are currently in the hospital for heart failure and are on low doses of standard medications.

Long Xuyen, An Giang
NCT07513883Recruiting· Phase 4
Reducing Heart Failure Medications When Your Heart Recovers

This study tests whether patients whose heart failure has improved can safely reduce some of their medications. If your heart function has recovered significantly and stayed stable, this trial explores whether you can gradually lower doses of heart failure drugs while staying healthy.

Genk
NCT07821801Not yet recruiting
Short-term results of standard heart failure treatment

This study looks at how well patients with heart failure who have reduced pumping function do when they receive the standard recommended medications. It aims to see short-term improvements in heart function and symptoms.

Hear when a new Heart Failure, Reduced Ejection Fraction trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.